Latest filing published 31 Jan 2023 for Vertex Pharmaceuticals INC / MA, €112k.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Yuchun Lee: trading record in brief
Yuchun Lee discloses dealings in 2 companies, chiefly Unica Corp and Vertex Pharmaceuticals INC / MA. Between 13 December 2005 and 27 January 2023, the trades on record add up to 665 filings.
The open-market record consists of 591 sales worth €22.1M, with no purchase. Outside the open market, there are 12 share grants and 36 option exercises. In 2023 alone, the filings show no purchases and 17 sales.
Most recently, on 31 January 2023, the filings show an open-market sale worth €112k in Vertex Pharmaceuticals INC / MA. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Yuchun Lee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 379 shares@ US$321.310.5% of flowCommon StockSEC:0001209191-23-005712:1
- 970 shares@ US$322.201.3% of flowCommon StockSEC:0001209191-23-005712:2
- 80 shares@ US$323.330.1% of flowCommon StockSEC:0001209191-23-005712:3
- 1,429 shares@ US$72.145.7% of flowCommon StockSEC:0001209191-23-005712:0
- 800 shares@ US$312.801.1% of flowCommon StockSEC:0001209191-23-005234:1
- 2,621 shares@ US$314.103.5% of flowCommon StockSEC:0001209191-23-005234:2
- 302 shares@ US$315.420.4% of flowCommon StockSEC:0001209191-23-005234:5
- 1,140 shares@ US$316.821.5% of flowCommon StockSEC:0001209191-23-005234:6
- 1,000 shares@ US$317.951.4% of flowCommon StockSEC:0001209191-23-005234:7
- 478 shares@ US$319.250.7% of flowCommon StockSEC:0001209191-23-005234:8
- 400 shares@ US$320.250.5% of flowCommon StockSEC:0001209191-23-005234:9
- 680 shares@ US$320.940.9% of flowCommon StockSEC:0001209191-23-005234:10
- 4,000 shares@ US$72.141.2% of flowCommon StockSEC:0001209191-23-005234:4
- 579 shares@ US$314.950.8% of flowCommon StockSEC:0001209191-23-005234:3
- 4,000 shares@ US$72.1415.9% of flowCommon StockSEC:0001209191-23-005234:0
- 2,129 shares@ US$312.022.9% of flowCommon StockSEC:0001209191-23-004816:1
- 4,000 shares@ US$72.141.2% of flowCommon StockSEC:0001209191-23-004816:2
- 2,511 shares@ US$312.293.4% of flowCommon StockSEC:0001209191-23-004816:3
- 1,489 shares@ US$313.362.0% of flowCommon StockSEC:0001209191-23-004816:4
- 2,129 shares@ US$72.148.5% of flowCommon StockSEC:0001209191-23-004816:0
- 4,000 shares@ US$312.035.4% of flowCommon StockSEC:0001209191-23-004005:1
- 442 shares@ US$72.140.1% of flowCommon StockSEC:0001209191-23-004005:2
- 442 shares@ US$312.170.6% of flowCommon StockSEC:0001209191-23-004005:3
- 4,000 shares@ US$72.1416.0% of flowCommon StockSEC:0001209191-23-004005:0
- 382 shares@ US$282.700.5% of flowCommon StockSEC:0000899243-22-015163:1
25 of 646 declarations
